SAN DIEGO--(BUSINESS WIRE)--DJO Incorporated (“DJO” or the “Company”), a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the preliminary results of its operating subsidiary, DJO Finance LLC’s (“DJOFL”) previously announced cash tender offer for any and all of its 11¾% Senior Subordinated Notes due 2014 (CUSIP No. 75524TAA3) (the “Notes”).
